CMPX logo

Compass Therapeutics (CMPX)

Profile

Full Name

Compass Therapeutics, Inc.

Ticker Symbol

CMPX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 5, 2021

Indexes

Not included

Website

http://www.compasstherapeutics.com

Employees

35

Key Details

Price

$1.70(0.00%)

Market cap

$235.08M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$850.00K

Annual EPS

-$0.36(-9.09% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.70
CMPX price is $1.70

30-Day Relative Volume

0.27
CMPX 30-day relative volume is 0.27

Price Performance

Price Today change

0%
CMPX {parameterFullLabel} is unchanged today

Price YTD change

+17.24%
CMPX price is up +17.24% since January 1st

Price 1-year change

+8.28%
CMPX price is up +8.28% year-on-year

Price 3-year change

+11.11%
CMPX price is up +11.11% over the past 3 years

Price Range

Price All-time high

$11.00
CMPX price is currently -84.55% below its historical high of $11.00

Price 3-year low

$0.77
CMPX price is currently +122.22% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$235.08M
CMPX market capitalization is $235.08 million

Market cap 3-year change

+51.7%
CMPX market capitalization is up +51.7% over the past 3 years

Market cap All-time high

$692.13M
CMPX market capitalization is currently -66.04% below its historical high of $692.13 million

Market cap sector rank

59.95%
CMPX market capitalization is higher than 59.95% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.5%
CMPX shares outstanding is up +0.5% year-on-year

Shares Outstanding 3-Year Change

+36.53%
CMPX shares outstanding is up +36.53% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.64
CMPX beta is 1.64

200-day SMA

$1.83
CMPX price is currently -7.09% below its 200-day simple moving average

50-day SMA

$2.53
CMPX price is currently -32.68% below its 50-day simple moving average

RSI

39.31
CMPX 14-day relative strength index is 39.31

Volume

0.27
CMPX 30-day relative volume is 0.27

ATR

$0.21
CMPX average true range is $0.21

10-day Historical Volatility

93.09%
CMPX 10-day historical volatility is 93.09%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$850.00K
CMPX annual revenue is $850.00 thousand

Revenue Analysts estimate

-
CMPX annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
CMPX annual revenue 1-year change is unknown

Revenue Sector rank

11.73%
CMPX annual revenue is higher than 11.73% of companies in Healthcare sector

EPS

EPS

-$0.36
CMPX annual earnings per share is -$0.36

EPS Analysts estimate

-$0.47
CMPX annual earnings per share is currently -22.86% lower than the consensus analysts' forecast

EPS 1-year change

-9.09%
CMPX annual earnings per share is down -9.09% year-on-year

EPS Sector rank

72.49%
CMPX annual earnings per share is higher than 72.49% of companies in Healthcare sector

Profit

Gross profit

-
CMPX annual gross profit value is unknown

Gross margin

-
CMPX annual gross profit margin value is unknown

Operating profit

-$56.63M
CMPX annual operating income is -$56.63 million

Operating margin

-6661.76%
CMPX annual operating profit margin is -6661.76%

Net income

-$49.38M
CMPX annual net profit is -$49.38 million

Net margin

-5808.82%
CMPX annual net profit margin is -5808.82%

Expenses

Total expenses

$57.48M
CMPX annual total expenses is $57.48 million

Operating expenses

$57.48M
CMPX annual total operating expenses is $57.48 million

Cost of goods sold

-
CMPX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$15.13M
CMPX annual SGA is $15.13 million

Depreciation and amortization

$1.75M
CMPX annual depreciation & amortization is $1.75 million

Interest expense

-
CMPX annual interest expense value is unknown

Income tax

$0.00
CMPX annual income tax is $0.00

EBIT & EBITDA

EBIT

-$56.63M
CMPX annual earnings before interest & taxes is -$56.63 million

EBITDA

-$54.87M
CMPX annual EBITDA is -$54.87 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$140.40M
CMPX annual total assets is $140.40 million

Non current assets

$7.65M
CMPX annual long term assets is $7.65 million

Current assets

$132.75M
CMPX annual total current assets is $132.75 million

Cash and cash equivalents

$43.48M
CMPX annual cash & cash equivalents is $43.48 million

Accounts receivable

-
CMPX annual accounts receivable value is unknown

Inventory

-
CMPX annual inventory value is unknown

Liabilities

Total liabilities

$15.17M
CMPX annual total liabilities is $15.17 million

Long term liabilities

$6.30M
CMPX annual total long term liabilities is $6.30 million

Current liabilities

$8.87M
CMPX annual total current liabilities is $8.87 million

Accounts payable

$2.25M
CMPX annual accounts payable is $2.25 million

Debt

Total debt

$6.63M
CMPX annual total debt is $6.63 million

Total debt 1-year change

+282.8%
CMPX annual total debt is up +282.8% year-on-year

Long term debt

$6.30M
CMPX annual long term debt is $6.30 million

Short term debt

$338.00K
CMPX annual short term debt is $338.00 thousand

Equity & Capital

Shareholders equity

$125.23M
CMPX annual stockholders equity is $125.23 million

Book value

$125.23M
CMPX annual book value is $125.23 million

Retained earnings

-$364.68M
CMPX annual retained earnings is -$364.68 million

Working capital

$123.88M
CMPX annual working capital is $123.88 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$44.85M
CMPX annual cash flow from operations is -$44.85 million

Cash from operations 1-year change

-10.43%
CMPX annual cash flow from operations is down -10.43% year-on-year

Cash from investing

$46.77M
CMPX annual cash flow from investing activities is $46.77 million

Cash from investing 1-year change

+73.45%
CMPX annual cash flow from investing activities is up +73.45% year-on-year

Cash from financing

$17.34M
CMPX annual cash flow from financing activities is $17.34 million

Cash from financing 1-year change

+490.73%
CMPX annual cash flow from financing activities is up +490.73% year-on-year

CAPEX

CAPEX

$44.00K
CMPX annual capital expenditures is $44.00 thousand

CAPEX 1-year change

-
CMPX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$44.90M
CMPX annual free cash flow is -$44.90 million

Free cash flow 1-year change

-10.46%
CMPX annual free cash flow is down -10.46% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CMPX annual gross profit margin value is unknown

Operating margin

-6661.76%
CMPX annual operating profit margin is -6661.76%

Net margin

-5808.82%
CMPX annual net profit margin is -5808.82%

ROA & ROE

ROA

-35.17%
CMPX annual return on assets is -35.17%

ROE

-36.07%
CMPX annual return on equity is -36.07%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CMPX price to earnings ratio value is unknown

PE ratio Sector rank

-
CMPX price to earnings ratio is unknown

PB Ratio

PB ratio

1.88
CMPX price to book ratio is 1.88

PB ratio Sector rank

61.07%
CMPX price to book ratio is higher than 61.07% of companies in Healthcare sector

PS Ratio

PS ratio

-
CMPX price to sales ratio value is unknown

PS ratio Sector rank

-
CMPX price to sales ratio is unknown

Enterprise value

Enterprise value

$198.23M
CMPX enterprise value is $198.23 million

Enterprise value Sector rank

59.22%
CMPX enterprise value is higher than 59.22% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.61
CMPX EV/EBITDA is -3.61

EV/EBITDA Sector rank

22.98%
CMPX EV/EBITDA is higher than 22.98% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

14.96
CMPX annual current ratio is 14.96

Quick ratio

-
CMPX annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CMPX annual debt to equity ratio is 0.00

Interest coverage ratio

-
CMPX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CMPX piotroski f-score value is unknown

Altman Z-Score

5.39
CMPX altman z-score is 5.39

Analyst ratings

Recent major analysts updates

Apr 4, 25 HC Wainwright & Co.
Buy
Apr 2, 25 Leerink Partners
Outperform
Apr 2, 25 Guggenheim
Buy
Apr 1, 25 D. Boral Capital
Buy
Feb 27, 25 D. Boral Capital
Buy
Feb 25, 25 D. Boral Capital
Buy
Feb 24, 25 Guggenheim
Buy
Feb 19, 25 Piper Sandler
Overweight
Feb 10, 25 Jefferies
Buy
Jan 10, 25 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

MNPR logo
Monopar Therapeutics (MNPR)
CADL logo
Candel Therapeutics (CADL)
ACB logo
Aurora Cannabis (ACB)
LFCR logo
Lifecore Biomedical (LFCR)
ATXS logo
Astria Therapeutics (ATXS)
ABEO logo
Abeona Therapeutics (ABEO)
HUMA logo
Humacyte (HUMA)
THRD logo
Third Harmonic Bio (THRD)
OABI logo
OmniAb (OABI)
  • What is the ticker symbol for Compass Therapeutics?
  • Does Compass Therapeutics pay dividends?
  • What sector is Compass Therapeutics in?
  • What industry is Compass Therapeutics in?
  • What country is Compass Therapeutics based in?
  • When did Compass Therapeutics go public?
  • Is Compass Therapeutics in the S&P 500?
  • Is Compass Therapeutics in the NASDAQ 100?
  • Is Compass Therapeutics in the Dow Jones?
  • When was Compass Therapeutics's last earnings report?
  • When does Compass Therapeutics report earnings?
  • Should I buy Compass Therapeutics stock now?

What is the ticker symbol for Compass Therapeutics?

The ticker symbol for Compass Therapeutics is NASDAQ:CMPX

Does Compass Therapeutics pay dividends?

No, Compass Therapeutics does not pay dividends

What sector is Compass Therapeutics in?

Compass Therapeutics is in the Healthcare sector

What industry is Compass Therapeutics in?

Compass Therapeutics is in the Biotechnology industry

What country is Compass Therapeutics based in?

Compass Therapeutics is headquartered in United States

When did Compass Therapeutics go public?

Compass Therapeutics's initial public offering (IPO) was on April 5, 2021

Is Compass Therapeutics in the S&P 500?

No, Compass Therapeutics is not included in the S&P 500 index

Is Compass Therapeutics in the NASDAQ 100?

No, Compass Therapeutics is not included in the NASDAQ 100 index

Is Compass Therapeutics in the Dow Jones?

No, Compass Therapeutics is not included in the Dow Jones index

When was Compass Therapeutics's last earnings report?

Compass Therapeutics's most recent earnings report was on Feb 27, 2025

When does Compass Therapeutics report earnings?

The next expected earnings date for Compass Therapeutics is May 13, 2025

Should I buy Compass Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page